Stocks were firm on Tuesday morning during a shortened week that will be full of economic reports. 24/7 Wall St. reviews dozens of analyst research reports each morning of the week for new ideas for our readers. Some of the analyst research reports cover stocks to buy, and some of them cover stocks to sell or to avoid.
As this is the first day of the second half of 2014, we already ran the best performing DJIA stocks and also the best performing S&P 500 stocks so far in 2014. These are this Tuesday’s top analyst upgrades, downgrades and initiations from Wall Street firms.
Amicus Therapeutics Inc. (NASDAQ: FOLD) already had a great Monday with a gain of more than 10% to $3.34, but the stock did rise as much as $4.06. Now we have two more upgrades: to Buy from Neutral at Janney with a $5 price target (from $2.50) and to Outperform from Market Perform at Leerink Swann.
comScore Inc. (NASDAQ: SCOR) was raised to Buy from Neutral and the price target was raised to $41 (versus a $35.48 close) by Goldman Sachs.
Expedia Inc. (NASDAQ: EXPE) was started with an Outperform rating and was assigned a $90 price target (versus a $78.76 close) at Oppenheimer.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.